Ivp Share Price
Sector: Chemical Manufacturing
180.80 -6.00 (-3.21%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
180.60
Today’s High
189.00
52 Week Low
141.00
52 Week High
267.00
183.10 -4.13 (-2.21%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
181.20
Today’s High
190.79
52 Week Low
140.91
52 Week High
266.60
Key Metrics
- Market Cap (In Cr) 186.74
- Beta 1.44
- Div. Yield (%) 0.54
- P/B 1.37
- TTM P/E 13.23
- Peg Ratio -1.23
- Sector P/E 17.07
- D/E 0.01
- Open Price 188.95
- Prev Close 186.8
Ivp Analysis
Price Analysis
-
1 Week10.79%
-
3 Months14.98%
-
6 Month-6.67%
-
YTD-12.36%
-
1 Year9.98%
Risk Meter
- 60% Low risk
- 60% Moderate risk
- 60% Balanced Risk
- 60% High risk
- 60% Extreme risk
Ivp News
UiPath raises $225 million Series E funding, valued at $10.2 billion
2 min read . 13 Jul 2020Ivp Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 538.99
- Selling/ General/ Admin Expenses Total
- 21.56
- Depreciation/ Amortization
- 5.73
- Other Operating Expenses Total
- 58.89
- Total Operating Expense
- 519.52
- Operating Income
- 19.47
- Net Income Before Taxes
- 15.26
- Net Income
- 11.31
- Diluted Normalized EPS
- 10.96
- Period
- 2025
- Total Assets
- 347.57
- Total Liabilities
- 208.24
- Total Equity
- 139.33
- Tangible Book Valueper Share Common Eq
- 133.44
- Period
- 2025
- Cashfrom Operating Activities
- -2.47
- Cashfrom Investing Activities
- -4.71
- Cashfrom Financing Activities
- 6.28
- Net Changein Cash
- -0.9
- Period
- 2024
- Total Revenue
- 546.1
- Selling/ General/ Admin Expenses Total
- 56.84
- Depreciation/ Amortization
- 5.54
- Other Operating Expenses Total
- -0.2
- Total Operating Expense
- 520.73
- Operating Income
- 25.37
- Net Income Before Taxes
- 16.63
- Net Income
- 12.28
- Diluted Normalized EPS
- 11.96
- Period
- 2024
- Total Assets
- 330.93
- Total Liabilities
- 201.31
- Total Equity
- 129.62
- Tangible Book Valueper Share Common Eq
- 125.44
- Period
- 2024
- Cashfrom Operating Activities
- 45.4
- Cashfrom Investing Activities
- -3.46
- Cashfrom Financing Activities
- -40.57
- Net Changein Cash
- 1.37
- Period
- 2023
- Total Revenue
- 660.95
- Selling/ General/ Admin Expenses Total
- 52.38
- Depreciation/ Amortization
- 5.18
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 610.76
- Operating Income
- 50.19
- Net Income Before Taxes
- 37.95
- Net Income
- 28.02
- Diluted Normalized EPS
- 27.13
- Period
- 2023
- Total Assets
- 383.73
- Total Liabilities
- 265.05
- Total Equity
- 118.68
- Tangible Book Valueper Share Common Eq
- 114.8
- Period
- 2023
- Cashfrom Operating Activities
- 40.61
- Cashfrom Investing Activities
- 9.94
- Cashfrom Financing Activities
- -50.69
- Net Changein Cash
- -0.14
- Period
- 2022
- Total Revenue
- 556.58
- Selling/ General/ Admin Expenses Total
- 48.7
- Depreciation/ Amortization
- 5.08
- Total Operating Expense
- 526.4
- Operating Income
- 30.18
- Net Income Before Taxes
- 23.35
- Net Income
- 17.63
- Diluted Normalized EPS
- 17.3
- Period
- 2022
- Total Assets
- 370.54
- Total Liabilities
- 278.83
- Total Equity
- 91.71
- Tangible Book Valueper Share Common Eq
- 88.66
- Period
- 2022
- Cashfrom Operating Activities
- -20.71
- Cashfrom Investing Activities
- -2.89
- Cashfrom Financing Activities
- 22.59
- Net Changein Cash
- -1.01
- Period
- 2021
- Total Revenue
- 289.68
- Selling/ General/ Admin Expenses Total
- 37.59
- Depreciation/ Amortization
- 5.02
- Other Operating Expenses Total
- -0.1
- Total Operating Expense
- 275.99
- Operating Income
- 13.69
- Net Income Before Taxes
- 6.68
- Net Income
- 4.5
- Diluted Normalized EPS
- 4.44
- Period
- 2021
- Total Assets
- 303.95
- Total Liabilities
- 228.25
- Total Equity
- 75.7
- Tangible Book Valueper Share Common Eq
- 73.08
- Period
- 2021
- Cashfrom Operating Activities
- -14.14
- Cashfrom Investing Activities
- -0.33
- Cashfrom Financing Activities
- 15.95
- Net Changein Cash
- 1.48
- Period
- 2020
- Total Revenue
- 228.76
- Selling/ General/ Admin Expenses Total
- 37.39
- Depreciation/ Amortization
- 4.86
- Other Operating Expenses Total
- 0.6
- Total Operating Expense
- 231.52
- Operating Income
- -2.76
- Net Income Before Taxes
- -12.83
- Net Income
- -8.62
- Diluted Normalized EPS
- -8.37
- Period
- 2020
- Total Assets
- 220.2
- Total Liabilities
- 148.44
- Total Equity
- 71.76
- Tangible Book Valueper Share Common Eq
- 69.18
- Period
- 2020
- Cashfrom Operating Activities
- 56.43
- Cashfrom Investing Activities
- -4.99
- Cashfrom Financing Activities
- -54.05
- Net Changein Cash
- -2.61
- Period
- 2019
- Total Revenue
- 319.88
- Selling/ General/ Admin Expenses Total
- 34.31
- Depreciation/ Amortization
- 2.86
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 310.69
- Operating Income
- 9.19
- Net Income Before Taxes
- 0.28
- Net Income
- 3.38
- Diluted Normalized EPS
- 3.3
- Period
- 2019
- Total Assets
- 274.6
- Total Liabilities
- 193.02
- Total Equity
- 81.58
- Tangible Book Valueper Share Common Eq
- 78.62
- Period
- 2019
- Cashfrom Operating Activities
- -26.7
- Cashfrom Investing Activities
- -27.85
- Cashfrom Financing Activities
- 54.08
- Net Changein Cash
- -0.47
- Period
- 2025-03-31
- Total Revenue
- 149.36
- Selling/ General/ Admin Expenses Total
- 5.17
- Depreciation/ Amortization
- 1.46
- Other Operating Expenses Total
- 16.86
- Total Operating Expense
- 143.05
- Operating Income
- 6.31
- Net Income Before Taxes
- 5.15
- Net Income
- 3.83
- Diluted Normalized EPS
- 3.71
- Period
- 2025-03-31
- Total Assets
- 347.57
- Total Liabilities
- 208.24
- Total Equity
- 139.33
- Tangible Book Valueper Share Common Eq
- 133.44
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -2.47
- Cashfrom Investing Activities
- -4.71
- Cashfrom Financing Activities
- 6.28
- Net Changein Cash
- -0.9
- Period
- 2024-12-31
- Total Revenue
- 129.36
- Selling/ General/ Admin Expenses Total
- 5.44
- Depreciation/ Amortization
- 1.47
- Other Operating Expenses Total
- 15.29
- Total Operating Expense
- 125.75
- Operating Income
- 3.61
- Net Income Before Taxes
- 2.6
- Net Income
- 1.89
- Diluted Normalized EPS
- 1.84
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 122.01
- Selling/ General/ Admin Expenses Total
- 5.54
- Depreciation/ Amortization
- 1.41
- Other Operating Expenses Total
- 13.14
- Total Operating Expense
- 117.89
- Operating Income
- 4.12
- Net Income Before Taxes
- 3.09
- Net Income
- 2.16
- Diluted Normalized EPS
- 2.09
- Period
- 2024-09-30
- Total Assets
- 330.03
- Total Liabilities
- 196.08
- Total Equity
- 133.95
- Tangible Book Valueper Share Common Eq
- 128.56
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -1.83
- Cashfrom Investing Activities
- -2.75
- Cashfrom Financing Activities
- 3.67
- Net Changein Cash
- -0.91
- Period
- 2024-06-30
- Total Revenue
- 138.26
- Selling/ General/ Admin Expenses Total
- 5.41
- Depreciation/ Amortization
- 1.39
- Other Operating Expenses Total
- 13.6
- Total Operating Expense
- 132.83
- Operating Income
- 5.43
- Net Income Before Taxes
- 4.42
- Net Income
- 3.43
- Diluted Normalized EPS
- 3.32
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 142.22
- Selling/ General/ Admin Expenses Total
- 5.2
- Depreciation/ Amortization
- 1.39
- Other Operating Expenses Total
- 13.32
- Total Operating Expense
- 134.79
- Operating Income
- 7.43
- Net Income Before Taxes
- 6.41
- Net Income
- 4.74
- Diluted Normalized EPS
- 4.59
- Period
- 2024-03-31
- Total Assets
- 330.93
- Total Liabilities
- 201.31
- Total Equity
- 129.62
- Tangible Book Valueper Share Common Eq
- 125.44
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 45.4
- Cashfrom Investing Activities
- -3.46
- Cashfrom Financing Activities
- -40.57
- Net Changein Cash
- 1.37
- Period
- 2023-12-31
- Total Revenue
- 122.33
- Selling/ General/ Admin Expenses Total
- 5.32
- Depreciation/ Amortization
- 1.4
- Other Operating Expenses Total
- 14.24
- Total Operating Expense
- 118.64
- Operating Income
- 3.69
- Net Income Before Taxes
- 2.38
- Net Income
- 1.71
- Diluted Normalized EPS
- 1.66
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Ivp Technical
Moving Average
SMA
- 5 Day181.89
- 10 Day174.54
- 20 Day170.71
- 50 Day160.7
- 100 Day176.48
- 300 Day195.63
Ivp Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aksharchem India
- 244.2
- -4.85
- -1.95
- 376
- 193
- 195.65
- Narmada Gelatines
- 341.8
- 14.95
- 4.57
- 449.4
- 300
- 206.74
- Ivp
- 180.8
- -6
- -3.21
- 267
- 141
- 186.74
- Oriental Carbon & Chemicals
- 193
- 0.15
- 0.08
- 415
- 151
- 191.67
- Syschem India
- 41.95
- 1.31
- 3.22
- 57.95
- 35.33
- 182.45
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aksharchem India
- -
- 0.77
- 1.8
- 1.61
- Narmada Gelatines
- 12.9
- 1.81
- 10.14
- 8.04
- Ivp
- 17.08
- 1.39
- 14.15
- 2.84
- Oriental Carbon & Chemicals
- 4.19
- 0.3
- 10.8
- 13.94
- Syschem India
- 372.84
- 1.94
- 0.32
- 0.05
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 15-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 11-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 27-Apr-23
- Audited Results & Final Dividend
- 09-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 11-Oct-24
- 18-Sept-24
- POM
- 08-Aug-24
- 16-Jul-24
- AGM
- 10-Aug-23
- 12-Jul-23
- AGM
- 28-Jul-22
- 30-Jun-22
- AGM
- 28-Jul-21
- 01-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 15-May-25
- -
- -
- 1
- 23-May-24
- -
- 01-Aug-24
- 1
- 27-Apr-23
- -
- 03-Aug-23
- 1.5
- 17-May-22
- -
- 20-Jul-22
- 1.5
- 11-Jun-21
- -
- 19-Jul-21
- 1


